NCT04293471

Brief Summary

Patients with left bundle branch block have an increased risk for the development of heart-failure and death. However, risk factors for unfavorable outcomes are still poorly defined. This study aims to identify echocardiographic parameters and ECG characteristics by machine learning in order to develop individual risk assessment

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
129mo left

Started Apr 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress32%
Apr 2021Dec 2036

First Submitted

Initial submission to the registry

March 1, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 3, 2020

Completed
1.1 years until next milestone

Study Start

First participant enrolled

April 15, 2021

Completed
6.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2036

Last Updated

May 24, 2022

Status Verified

May 1, 2022

Enrollment Period

6.7 years

First QC Date

March 1, 2020

Last Update Submit

May 18, 2022

Conditions

Keywords

Left bundle branch blockstrain-imagingmyocardial work assessmentmachine learning

Outcome Measures

Primary Outcomes (2)

  • Cardiovascular death

    Timepoint (day) of death and its cause

    15 years

  • Death of any cause

    Timepoint (day) of death and its cause

    15 years

Secondary Outcomes (1)

  • Hospital admission due to heart-failure

    15 years

Other Outcomes (3)

  • Remodelling

    5 years

  • Cardiac function

    5 years

  • Heart failure

    5 years

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients will be recruited based on epidemiological studies from Tromsø, where LBBB or ventricular pacing has been identified. Further in-hospital patients and patients from the out-patient clinics will be recruited due to ECG assessment

You may qualify if:

  • QRS complex \>130 ms and R-wave duration in
  • V6 \>70 ms
  • ventricular pacing\>50%
  • Previously implanted cardiac resynchronisation therapy (CRT)

You may not qualify if:

  • Typical right bundle branch block.
  • No ability to give informed consent,
  • non-cardiovascular co-mobidities with reduced life-expectancy \< 1 year
  • patients with complex congenital heart disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital North Norway

Tromsø, Troms, 9038, Norway

RECRUITING

MeSH Terms

Conditions

Bundle-Branch Block

Condition Hierarchy (Ancestors)

Heart BlockArrhythmias, CardiacHeart DiseasesCardiovascular DiseasesCardiac Conduction System DiseasePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Assami Rösner, MD,PhD

    University Hospital North Norway

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Assami Rösner, MD,PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
15 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD PhD

Study Record Dates

First Submitted

March 1, 2020

First Posted

March 3, 2020

Study Start

April 15, 2021

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2036

Last Updated

May 24, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will share

All individual analytic codes for participants fom other Norwegian Hospitals need to be transferred to University Hospital North Norway (UNN) for registering outcome follow-up

Shared Documents
STUDY PROTOCOL, ICF, CSR, ANALYTIC CODE
Time Frame
15 years
Access Criteria
Patient have been included and five-year outcome data will have been revised.

Locations